Heptagon Capital at SuperReturn 2024
Heptagon Capital is gearing up for the #SuperReturn International Conference 2024 next month in Berlin!
Our Institutional Sales Team, including Naz Hedayat, Michael Daly, Natalia Greslikova and Tabea-Sophie Kuester are excited to meet with investors and connect with industry peers from across the private markets’ space.
The team will also showcase healthcare royalties investing – an innovative investment strategy offering an uncorrelated and low beta return profile compared with traditional PE and other asset classes such as equities and fixed-income. Dive into our white paper to learn more: https://www.heptagon-capital.com/static/uploads/1715338883/Unlocking-Value-Through-Healthcare-Royalties-WhitePaper.pdf
We look forward to connecting with you for engaging discussions and new opportunities!
To schedule a meeting, please reach out to [email protected].
Disclaimers
The document is provided for information purposes only and does not constitute investment advice or any recommendation to buy, or sell or otherwise transact in any investments. The document is not intended to be construed as investment research. The contents of this document are based upon sources of information which Heptagon Capital LLP believes to be reliable. However, except to the extent required by applicable law or regulations, no guarantee, warranty or representation (express or implied) is given as to the accuracy or completeness of this document or its contents and, Heptagon Capital LLP, its affiliate companies and its members, officers, employees, agents and advisors do not accept any liability or responsibility in respect of the information or any views expressed herein. Opinions expressed whether in general or in both on the performance of individual investments and in a wider economic context represent the views of the contributor at the time of preparation. Where this document provides forward-looking statements which are based on relevant reports, current opinions, expectations and projections, actual results could differ materially from those anticipated in such statements. All opinions and estimates included in the document are subject to change without notice and Heptagon Capital LLP is under no obligation to update or revise information contained in the document. Furthermore, Heptagon Capital LLP disclaims any liability for any loss, damage, costs or expenses (including direct, indirect, special and consequential) howsoever arising which any person may suffer or incur as a result of viewing or utilising any information included in this document.
The document is protected by copyright. The use of any trademarks and logos displayed in the document without Heptagon Capital LLP’s prior written consent is strictly prohibited. Information in the document must not be published or redistributed without Heptagon Capital LLP’s prior written consent.
Heptagon Capital LLP, 63 Brook Street, Mayfair, London W1K 4HS
tel +44 20 7070 1800
email [email protected]
Partnership No: OC307355 Registered in England and Wales Authorised & Regulated by the Financial Conduct Authority
Heptagon Capital Limited is licenced to conduct investment services by the Malta Financial Services Authority.
